NCT06221332 Sacral Erector Spinae Plane Block in Normal Birth
| NCT ID | NCT06221332 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Konya City Hospital |
| Condition | Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-01-24 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-01-24 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pregnant women feel severe pain during normal birth and in the postpartum period. Preventing pain during and after birth is very important for both the mother and the baby. Rapid recovery in the postoperative period in pregnant women is very important for both mother and baby. To evaluate this recovery, the quality of recovery-10 scores developed by Shalev et al. are used in pregnant women. Our study will be the first in the literature to use sacral erectör spinae plane block (S-ESPB) in normal birth. Our primary aim in this study is to evaluate the effects of S-ESPB on the quality of recovery and recovery at the 24th hour in pregnant women who will undergo vaginal birth with epidural analgesia, using the Quality of Recovery-10T scores.
Eligibility Criteria
Inclusion Criteria: * 36-42. Pregnant women who are their gestational age and request epidural anesthesia * Pregnant women aged 18-42 with ASA II * Pregnant women who will stay in the hospital for at least 24 hours * Primiparous pregnant women who will have a planned normal birth * Singleton births with vertex presentation Exclusion Criteria: * Pregnant women who do not want to give consent * Regional anesthesia is contraindicated * Pregnant women who use anticoagulants and have an abnormal bleeding profile * Pregnant women with infection in the area to be treated * Emergency cases and pregnant women who had a birth with instruments (forceps and vacuum)
Contact & Investigator
MUHAMMED H SATICI, M.D.
PRINCIPAL INVESTIGATOR
Konya City Hospital
Frequently Asked Questions
Who can join the NCT06221332 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 42 Years, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06221332 currently recruiting?
Yes, NCT06221332 is actively recruiting participants. Contact the research team at halit_satici@hotmail.com for enrollment information.
Where is the NCT06221332 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye).
Who is sponsoring the NCT06221332 clinical trial?
NCT06221332 is sponsored by Konya City Hospital. The principal investigator is MUHAMMED H SATICI, M.D. at Konya City Hospital. The trial plans to enroll 40 participants.